UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059878 |
|---|---|
| Receipt number | R000068478 |
| Scientific Title | A Study on ADL Assessment Using Motion Capture Systems |
| Date of disclosure of the study information | 2025/11/26 |
| Last modified on | 2025/11/25 20:36:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A Study on the Assessment of Activities of Daily Living Using Motion Capture Systems
Acronym
MCSADL Study
Scientific Title
A Study on ADL Assessment Using Motion Capture Systems
Scientific Title:Acronym
MCSADL Study
Region
| Japan |
Condition
Condition
Cerebrovascular disease, neuromuscular disease, orthopedic disease, cardiovascular disease, respiratory disease, disuse syndrome, and healthy individuals
Classification by specialty
| Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
| Cardiology | Pneumology | Endocrinology and Metabolism |
| Hematology and clinical oncology | Nephrology | Neurology |
| Clinical immunology | Geriatrics | Surgery in general |
| Gastrointestinal surgery | Hepato-biliary-pancreatic surgery | Vascular surgery |
| Chest surgery | Endocrine surgery | Orthopedics |
| Neurosurgery | Cardiovascular surgery | Emergency medicine |
| Intensive care medicine | Rehabilitation medicine | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Analyze ADL movements in healthy individuals and patients with various diseases using a markerless motion capture system. Furthermore, by comparing joint angles and joint moments derived from ADL movements using the markerless motion capture system, identify efficient movement patterns to develop optimized ADL movement instruction and training programs.
Basic objectives2
Others
Basic objectives -Others
Efficiency of ADL movements estimated using a markerless motion capture system
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Joint moments converted into variables for ADL movements using a markerless motion capture system
Key secondary outcomes
ADL movements were quantified using a markerless motion capture system to measure joint angles, joint range of motion, Brunnstrom Stage Test, Fugl-Meyer Assessment, presence of ataxia, SIAS, grip strength, pinch strength, manual muscle testing, Box and Block Test, Short Physical Performance Battery, isometric knee extension strength, Timed Up and Go Test, balance assessment, sensory testing, Mini-Mental State Examination, presence of attention deficits, presence of hemispatial neglect, presence of aphasia, presence of agnosia, presence of apraxia, presence of constructional apraxia, Functional Independence Measure score, and other tests deemed necessary and specific to various conditions.
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
Rehabilitation
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients must meet the following inclusion criteria.
Hospitalized patients with cerebrovascular disease, neuromuscular disorders, orthopedic conditions, cardiovascular disease, respiratory disorders, or disuse syndrome.
Adult patients aged 20 to 100 years who can understand the study explanation.
Patients who, after receiving sufficient explanation regarding participation in this study, can provide written consent based on their own free will.
Healthy individuals meeting the following inclusion criteria are eligible.
Medical staff employed at Kawasaki Municipal Tama Hospital or St. Marianna University Yokohama City Western Hospital.
Individuals who, after receiving sufficient explanation regarding participation in this study, can provide written consent based on their own free will.
Key exclusion criteria
Individuals deemed unsuitable for participation in the study by the researcher or attending physician due to changes in their medical condition or other reasons
Target sample size
203
Research contact person
Name of lead principal investigator
| 1st name | Hiroki |
| Middle name | |
| Last name | Oishi |
Organization
Kawasaki Municipal Tama Hospital
Division name
Rehabilitation Department
Zip code
214-8525
Address
1-30-37 Shukugawara, Tama Ward, Kawasaki City, Kanagawa Prefecture
TEL
0570-028-111
hiroki.oishi@marianna-u.ac.jp
Public contact
Name of contact person
| 1st name | Hiroki |
| Middle name | |
| Last name | Oishi |
Organization
Kawasaki Municipal Tama Hospital
Division name
Rehabilitation Department
Zip code
214-8525
Address
1-30-37 Shukugawara, Tama Ward, Kawasaki City, Kanagawa Prefecture
TEL
0570-028-111
Homepage URL
hiroki.oishi@marianna-u.ac.jp
Sponsor or person
Institute
St. Marianna University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kawasaki Municipal Tama Hospital
Address
1-30-37 Shukugawara, Tama Ward, Kawasaki City, Kanagawa Prefecture
Tel
0570-028-111
hiroki.oishi@marianna-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 11 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 11 | Month | 19 | Day |
Date of IRB
| 2025 | Year | 11 | Month | 19 | Day |
Anticipated trial start date
| 2025 | Year | 12 | Month | 01 | Day |
Last follow-up date
| 2030 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2030 | Year | 12 | Month | 31 | Day |
Date trial data considered complete
| 2030 | Year | 12 | Month | 31 | Day |
Date analysis concluded
| 2030 | Year | 12 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2025 | Year | 11 | Month | 25 | Day |
Last modified on
| 2025 | Year | 11 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068478
